Table 2

Baseline characteristics of the CVC population

Missing valuesAll patientsCAD presentCAD absentP value
(n=696)(n=113)(n=583)
Male sex0341 (49%)89 (79%)252 (43%)<0.001
Age, years065.6±12.672.1±10.364.3±12.6<0.001
Height, cm195170±10171±9170±100.053
BMI, kg/m220527.9±5.427.9±4.127.8±5.60.25
Systolic blood pressure, mm Hg73143±24146±22143±240.04
Diastolic blood pressure, mm Hg7385±1385±1185±130.79
Typical angina0214 (31%)73 (65%)141 (24%)<0.001
Atypical angina0263 (38%)18 (16%)245 (42%)<0.001
Asymptomatic0219 (31%)22 (19%)197 (34%)0.004
Shortness of breath0229 (33%)46 (41%)183 (31%)0.069
Non-smoker140256 (37%)36 (32%)220 (38%)0.28
Prior smoker140149 (21%)32 (28%)117 (20%)0.067
Current smoker140151 (22%)23 (20%)128 (22%)0.8
Diabetes075 (11%)17 (15%)58 (10%)0.152
Statin0308 (44%)87 (77%)221 (38%)<0.001
Platelet inhibitors0251 (36%)89 (79%)162 (28%)<0.001
ACE inhibitor or Angiotensine II receptor antagonist0244 (35%)51 (45%)193 (33%)0.019
Calcium antagonist0104 (15%)21 (19%)83 (14%)0.297
Beta-blockers0269 (39%)85 (75%)184 (32%)<0.001
Diuretics0130 (19%)21 (19%)109 (19%)>0.99
Nitrates0111 (16%)56 (50%)55 (9%)<0.001
Troponin, pg/mL05 (0–9)9 (5–17)5 (0–7)<0.001
Pancreas amylase, µmol/L028±1228±1128±130.707
Alkaline phosphatase, µmol/L068±2467±1869±250.933
Alanine amiotransferase (ALAT), µmol/L032±1833±1831±180.056
Bilirubin, µmol/L010±510±510±60.566
Urea, mmol/L05.5±1.96.1±2.25.4±1.80.001
Uric acid, µmol/L1321±89355±98314±86<0.001
Cholesterol (total), mmol/L05.5±1.35.1±1.45.5±1.20.001
LDL-cholesterol, mmol/L03.4±1.23.2±1.23.5±1.10.015
HDL-cholesterol, mmol/L01.3±0.41.1±0.31.3±0.4<0.001
Protein (total), g/L070±669±670±50.143
Albumin, g/L038.7±3.637.8±3.638.9±3.60.003
Glucose, mmol/L05.9±2.76.2±2.35.9±2.80.029
  • BMI, body mass index; CAD, coronary artery disease; CVC, cardiovascular clinic; HDL, high-density lipoprotein; LDL, low-density lipoprotein.